27 Pill - gray round, 8mm
Pill with imprint 27 is Gray, Round and has been identified as Methylphenidate Hydrochloride Extended-Release 27 mg. It is supplied by Amneal Pharmaceuticals LLC.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 27 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for 27
Methylphenidate Hydrochloride Extended-Release
- Imprint
- 27
- Strength
- 27 mg
- Color
- Gray
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 65162-0233 (Discontinued)
- Inactive Ingredients
-
mannitol,
sodium chloride,
silicon dioxide,
ethylcellulose,
fumaric acid,
hypromelloses,
polyethylene glycol,
microcrystalline cellulose,
povidone,
stearic acid,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferrosoferric oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "27"
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,090)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Chewable Tablets
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Professional resources
- Methylphenidate monograph
- Methylin Chewable Tablet (FDA)
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.